Based in the United States, Cypre is a startup.
Cypre develops a 3D tumor organoid platform using proprietary hydrogel technology to create human-derived tumor models that integrate tumor, stromal, and immune compartments for improving cancer drug development and translational research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.